Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, over-the-counter treatments and vaccines... Show more
SNY is expected to report earnings to fall 32.28% to 88 cents per share on April 24
Q1'25
Est.
$0.89
Q4'24
Beat
by $0.53
Q3'24
Beat
by $0.88
Q2'24
Beat
by $0.84
Q1'24
Beat
by $0.85
The last earnings report on January 30 showed earnings per share of $1.31, beating the estimate of 77 cents. With 419.35K shares outstanding, the current market capitalization sits at 122.61B.